PerkinElmer: Michel Vounatsos
PerkinElmer has appointed Michel Vounatsos to its board of directors, effective March 1. He is currently CEO of Biogen. Before that, he was at Merck, where he held several leadership positions, including president of the Primary Care Customer Business Line and Merck Customer Centricity. Earlier in his career, he held management positions at Ciba-Geigy.